Page 212 - Read Online
P. 212

Page 12 of 15                                                        Rodrigues et al. Vessel Plus 2024;8:10  https://dx.doi.org/10.20517/2574-1209.2023.109

               Table 2. Thoracoabdominal F/B-EVAR - Early outcomes
                                                                             Respiratory                  Temporary  Permanent   Any   GI    HLOS
                Author         Year  n  Extent   MAE   Death  AKI   Dialysis           MI      SCI
                                                                             failure                    paraplegia  Paraplegia  Stroke  resection (days)
                          [63]
                Oikonomou et al.     2019  71  -  13 (18,3) 4 (5.6)  2 (2.8)  2 (2.8)  -  -    11       9 (12,7)  2 (2.8)    -       -       11 (6-48)
                n (%) or mean (± SD)                                                           (15.5)
                     [64]
                Law et al.     2019  20  -       -     1 (5)  5 (25)  -      3 (15)    -       2 (10)   1 (5)     1 (5)      -       -       9 (± 13)
                n (%) or mean (± SD)
                Motta et al. [61]    2019  150  -  39 (26)  4 (2.7)  7 (4.7)  2 (1.3)  10 (7)    1   4 (2,7)  1 (0.7)  3 (2)  1 (0.7)  -     5.6 (± 5.4)
                n (%) or mean (± SD)                                                   (0.7)
                Rocha et al. [59]    2020  2,059 -  -  (7.4)  (11.7)  (6.4)  -         -       (13.5)   -         (5.2)      (2.7)   -       12.8
                (%) or mean (± SD)                                                                                                           (7,8-17,7)
                        [62]             IV (132)  30 (23)  (1.5)  24 (18)  3 (2)  4(3)  6 (5)  3 (2)   2 (2)     1 (1)      4 (3)   2 (2)   6.1 (± 4.6)
                Oderich et al.
                n (%), (%) or mean   2021   430  I - III (165)  34 (21)  (0.6)  18 (11)  3 (2)  7 (4)  1 (1)  20 (12)  13 (8)  7 (4)  5 (3)  0 (0)  9.6(± 10.7)
                (± SD)
                                         PRA (133)  19 (14)  (0.8)  14 (11)  2 (2)  1 (1)  11 (3)  2 (2)  0 (0)   2 (2)      1 (1)   4 (3)   4.8 (± 5.4)
                Zettervall et al. [65]    2022  1,681 I-III (644)   423   46 (3)  161   25 (2)  56 (3)  35 (2)  120 (7)  81 (5)  39 (2)  32 (2)  -  6.8 (± 9)
                US ARC                   IV (535)   (25)      (10)
                n (%) or mean (± SD)     CAAA
                                         (502)
               MAE: Major adverse events; AKI: acute kidney injury; SCI: spinal cord injury; MI: myocardial infarction; GI: gastrointestinal; HLOS: hospital length of stay; US ARC: United States aortic research consortium; PRA:
               pararenal aortic aneurysm; CAAA: complex abdominal aortic aneurysm. Categorical variables are presented as numbers (percent) or (percentage). Continuous variables are presented as mean (± standard
               deviation) or median (range).


               Results on open surgery repair were also analyzed by Coselli et al. . Out of 3,309 open repairs included in the study, there were 1,864 late deaths . Estimated
                                                                      [19]
                                                                                                                                         [19]
               survival was 83.5% ± 0.7% at 1 year, 63.6% ± 0.9% at 5 years, 36.8% ± 1.0% at 10 years, and 18.3% ± 0.9% at 15 years.

               CONCLUSION
               Endovascular treatment of TAAA has evolved widely and gained widespread acceptance due to reduced morbidity and mortality compared to open repair.
               Formerly reserved to treat high-risk patients, its indications are currently broadened and include young patients with suitable anatomy. Meticulous surgical
               planning, appropriate patient and device selection, and precise implantation technique are key to achieving optimal outcomes. Finally, technological
               advancements continue to develop rapidly, favoring better outcomes and expanding indications for this modality of repair.
   207   208   209   210   211   212   213   214   215   216   217